How over-the-top social media videos about psychedelics could undermine the field’s efforts to get its drugs approved.
Following Insmed’s decision to hold off on launching a newly approved lung disease drug in Europe, experts anticipate more ...
BIO-Europe Spring 2026 brought together more than 3,700 innovators in the life sciences industry all under the same roof.
The recent uptick in IPOs is an encouraging signal after a drought for much of 2025. Experts point to AI as a driving force behind this resurgence.
We explore what allosteric modulators are, their benefits and drawbacks, and which candidates are currently advancing through ...
ASX biotechs have enlisted to help the US military to protect soldiers against germ warfare attacks and – the enemy ... Read ...
The approval of Denali’s Hunter syndrome treatment, Avlayah, comes after a series of drug rejections and delays that had led ...
The rare disease space has always been uniquely difficult for drug development, but recent regulatory developments are ...
Ascendis Pharma (ASND), and Arrowhead Pharma (ARWR) make the cut as RBC names 13 top M&A contenders in biopharma. Read more ...
After a lengthy downturn, renewed optimism is building among young drugmakers and their backers as a new funding wave takes ...
They could make important breakthroughs in their target markets.
The Trump administration is already working to boost the industry — both by streamlining the regulatory process and forcing ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results